|
|
42
|
|
|
4331G
|
|
|
TASIGNA 150MG CAP (NVS) NILOTANIB
|
|
|
NILOTINIB
|
|
|
TASIGNA
|
|
|
112'S
|
|
|
C
|
|
|
7,611.31
|
|
|
67.96
|
|
|
150MG
|
|
|
CAP
|
|
|
0
|
|
|
BLIS
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
ORAL
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|